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SUMMARY 
D-3-hydroxybutyrate dehydrogenase (HBDH) from Pseudomonas fragi showed a strict 
stereospecificity to the D-enantiomer of 3-hydroxybutyrate (D-3-HB) as a substrate. The 
L-enantiomer acts as a competitive inhibitor, with a Ki value comparable to the Km value for D-3-HB. 
We have determined the crystal structures of the ternary complex of HBDH-NAD+-L-3-HB and the 
binary complex of HBDH-NAD+. The former structure showed a so-called closed-form conformation, 
which is considered an active form for catalysis, while the latter stayed mostly in a open-form 
conformation. The determined structures along with the site-directed mutagenesis confirmed the 
substrate recognition mechanism that we proposed previously.  
The hydrogen bonding interaction between Gln196, located in the moving helix, and the 
carboxyl group of the substrate/inhibitor is important for the stable ternary complex formation. 
Finally, the crystal structures of the Thr190 mutants, T190S and T190A, indicate that the Thr190 is a 
key residue for the open-closed conformational change. T190S retained 37% of the activity. In 
T190A, however, the activity decreased to 0.1% that of the wild-type enzyme. Fixing the position of 
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the hydroxyl group of Thr190 to form hydrogen bonds to the pyrophosphate moiety and the 
carboxamide of NAD+ seems to be a significant factor for the open-closed conformational change.  
 
Key words: hydroxybutyrate dehydrogenase; short-chain dehydrogenase/reductase family; crystal 
structure; conformational change; substrate recognition 
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INTRODUCTION 
D-3-hydroxybutyrate dehydrogenase (HBDH: EC 1.1.1.30) is an enzyme that reversibly oxidizes 
3-hydroxybutyrate to acetoacetate using NAD+ as a coenzyme. Mammals metabolize acetyl-CoA, which is 
formed during oxidation of fatty acids, by either of two pathways. One pathway is the citric acid cycle, 
while the other leads to acetoacetate and D-3-hydroxybutyrate, which, together with acetone, are 
collectively called ketone bodies. HBDH, a mitochondrial enzyme, reversibly reduces the free acetoacetate 
so produced into D-3-hydroxybutyrate (1). 
One of the severe complications of diabetes mellitus is diabetic ketoacidosis (DKA). DKA is 
caused by an increase of ketone bodies. It is important to monitor ketone bodies in the blood and urine of 
patients with diabetes mellitus (1). Mammalian HBDH is a mitochondrial enzyme that specifically requires 
phosphatidylcholine for activity (2). On the other hand, bacterial HBDH is a cytosolic enzyme and does not 
require phospholipids for its activity (3). Microbial enzymes have been used for the diagnostic analysis of 
ketone bodies for diabetes mellitus (4). 
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HBDH belongs to the SDR family (5). More than 30000 primary sequences are deposited in the 
sequence databases, and approximately 300 crystal structures are available. The SDR family enzymes act 
on a great variety of compounds and are divided into several EC classes, from oxidoreductases to 
isomerases. Moreover, within the subgroup of oxidoreductases to which most of the enzymes belong, 
diverse substrate specificities are found to act on a range of compounds, from steroids to aliphatic alcohols. 
The diversity of the SDR family might be in the same range as that of the CYP P450 family (6). The amino 
acid sequence identity among SDRs is relatively low, roughly 15-30%. However, the three-dimensional 
structures of the SDR family enzymes have architectures that are quite similar to each other, except for the 
substrate-binding loop region (7). Based on the functional assignments of coenzyme binding motifs, SDR 
family was divided into 5 subfamilies, called classical, extended, intermediate, divergent, and complex (8). 
The catalytic tetrad of Asn-Ser-Tyr-Lys is conserved in most of oxidoreductases in the family (9). Since 
some particular SDR members could be drug targets and some could be useful as enzyme reagents in 
organic synthesis or clinical chemistry, it is very important to understand the strategies used to recognize 
SDR substrates.  
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One of the striking features of SDR enzymes, mainly for the classical type, is a large 
conformational change upon substrate binding (5, 7, 10, 11). The most variable region of the 
substrate-binding loop moves to cover the substrate for catalysis. We have solved the crystal structures of 
the complex of HBDH from Pseudomonas fragi (PfHBDH) with a competitive inhibitor and with the 
inhibitor and NAD+ (5). While the structure of the PfHBDH-inhibitor complex showed an open-form 
conformation, that of the PfHBDH-NAD+-inhibitor complex showed a closed-form conformation. In the 
latter complex, however, the structure of the substrate-binding loop was disordered. Recently, three crystal 
structures closely related to the PfHBDH have been reported. DHRS6 is a human cytosolic type II HBDH 
having high Km and low kcat values (12). Two bacterial HBDHs, one from Pseudomonas putida (PpHBDH) 
and the other from Alcaligenes faecalis (AfHBDH), were also reported (13, 14). The structures of bacterial 
HBDHs contained a closed conformation.  
P. fragi HBDH catalyzed the dehydrogenation of only the D-enantiomer of 3-hydroxybutyrate. 
Our previous study indicated that this stringent substrate specificity was achieved through the recognition 
of the 3-methyl and carboxyl groups of the substrate. These two major interactions fixed both ends of the 
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substrate carbon chain. In the SDR family, a variable region known as a substrate-binding loop moves to 
cover the substrate upon substrate binding. As a result, only the 3R-configuration of the hydroxyl group is 
thought to orient to the catalytic tetrad of N114-S142-Y155-K159 of the enzyme, thus allowing the hydride 
transfer to occur. The hydrophobic pocket to accommodate the 3-methyl group is composed of Ala143, 
His144, Gly186, Trp187, and Trp257. The carboxyl group is recognized through interactions with Gln94, 
His144, and Lys152 (5).  
In this study, we constructed various site-directed mutants of PfHBDH to confirm the substrate 
recognition mechanism that we proposed in our previous work. Specific mutations were also introduced to 
Thr190 and Leu215, which are thought to function as hinges by which the substrate-binding loop moves to 
cover the bound substrate. Finally, we determined the structure of a ternary complex of HBDH, NAD+, and 
L-3-hydroxybutyrate as a closed form. These results allowed us to describe the detailed mechanisms 
underlying substrate recognition and conformational change.  
 
MATERIALS AND METHODS 
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Materials  
Restriction endonucleases and other DNA modification enzymes were purchased from TaKaRa 
Shuzo Co. The oligonucleotide primers were synthesized by Genenet. The BigDye terminator cycle 
sequencing kit and other reagents used for sequencing were obtained from Applied Biosystems. 
3-D(-)(3R)-hydroxybutyric acid sodium salt, 3-L(+)(3S)-hydroxybutyric acid sodium salt, and D-threonine 
were purchased from Sigma-Aldrich. Phenazine methosulfate (PMS), nitro blue tetrazolium (NBT), and 
Triton X-100 are products of Nacalai Tesque. NAD+ was from Kojin Kagaku. Polyethylene glycol, which 
was used for crystallization and had a mean molecular weight of 3000 (PEG3000), was purchased from 
Hampton Research. L-threonine, L-serine, and all other chemicals were of the highest grade available from 
Nacalai Tesque or Wako Pure Chemical Industries. 
 
Bacterial strains and plasmids 
E. coli DH5α (F-, 80dlacZΔM15, Δ(lacZYA-argF)U169, recA1, endA1, gyrA96, thi-1, supE44, 
relA1, hsdR17(r-, m+), deoR, phoA) and XL1Blue (Stratagene) were used for DNA manipulation and 
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protein expression. pGEM-T-easy (Promega) was used for cloning PCR products, and pQE30 (Qiagen) and 
pKK223-3 (Pharmacia) were used for protein expression.  
 
Site-directed mutagenesis 
Specific mutations were introduced into the gene by a PCR-based megaprimer method, which 
consisted of two rounds of PCR amplification (15). In the first round, one of the flanking primers and the 
internal mutagenic primer were used to generate a megaprimer. In the second round, another flanking 
primer and the megaprimer were used to generate the DNA fragment with the desired mutation. Table 1 
summarizes the mutagenic and flanking primers along with restriction enzymes used to ligate the DNA 
fragments containing the desired mutations into pHBDH11 or pHBDHX (pQE30). PCR conditions 
consisted of 25 cycles of denaturation at 95˚C for 30 sec, annealing at 57˚C for 30 sec, and extension at 
72˚C for 30 sec, with a final extension at 72˚C for 7 min. Amplified DNA fragments from the first round of 
PCR were purified by the QIAEX II kit (Qiagen) from agarose gel and used as megaprimers for the second 
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round of PCR. The condition consisted of 25 cycles of denaturation at 95˚C for 30 sec, annealing at 40˚C for 
60 sec, and extension at 72˚C for 60 sec.  
 
Purification of the recombinant enzymes 
The wild-type, Y155F, T190A, T190S, and T190C mutant enzymes were expressed in E. coli 
XL1Blue harboring pHBDH11 and its derivatives containing the specific mutations. The wild-type HBDH 
was purified as described previously (5). Four kinds of mutants (Y155F, T190A, T190S, and T190C) were 
purified by essentially the same procedure as that used for the wild-type enzyme. The wild-type HBDH 
containing an N-terminal histidine-tag (H6-HBDH) and the other mutant enzymes, each containing an 
N-terminal histidine tag, were expressed in E. coli XL1Blue using pQE30 as a vector. Briefly, the 
transformants were cultured in 2 liters of LB containing 50 mg/l ampicillin at 37˚C overnight. Cells were 
harvested by centrifugation at 10,000 x g for 15 min at 4˚C and resuspended in 300 ml of 20 mM Tris-HCl 
(pH 7.5). Cell lysates were prepared by repeated sonication in an ice bath using an Ultrasonic Disruptor 
UD200 (TOMY, Japan) followed by centrifugation at 15,000 x g for 20 min. The crude lysates were 
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directly applied onto a Ni-affinity column (GE Healthcare) and the column was washed with 500 ml of 20 
mM Tris-HCl buffer (pH 7.5) containing 0.5 M NaCl and 0.1 M imidazole. The adsorbed enzymes were 
eluted with 20 mM Tris-HCl buffer (pH 7.5) containing 0.5 M NaCl and 0.3 M imidazole, and the fractions 
showing significant absorbance at 280 nm were collected. Enzyme proteins in the collected fractions were 
precipitated by ammonium sulfate at 80% saturation. After centrifugation at 15,000 x g for 20 min, the 
enzymes were resuspended in a small volume of 20 mM Tris-HCl buffer (pH 7.5) and dialyzed against the 
same buffer. The dialysates were applied to a DEAE-Toyopearl 650C column and washed with the same 
buffer. The enzymes were eluted using a linear gradient from 0 to 0.5 M NaCl in the same buffer. Active 
fractions were collected and achieved 80% saturation of ammonium sulfate. After centrifugation at 15,000 
x g for 20 min, the enzymes were resuspended in a small volume of 10 mM Tris-HCl buffer (pH 7.5) and 
dialyzed against the same buffer. The purified enzymes were lyophilized and stored at -20˚C until use. 
SDS-PAGE analysis showed that all the purified enzymes were apparently homogeneous. The molecular 
mass of the wild-type enzyme was 27 kDa, and the enzymes having an N-terminal histidine tag were 




The kinetic parameters were determined by the Lineweaver-Burk plot using the initial rate data 
measured as described previously (5). While Km for D-3-HB was determined with various concentrations of 
D-3-HB (0.1 to 100 mM) in the presence of 2 mM NAD+, Km for NAD
+ was determined with various 
concentrations of NAD+ (0.1 to 2 mM) in the presence of 25 mM and 100 mM D-3-HB for the wild-type and 
mutant enzymes, respectively. Similarly, acetoacetate reduction was monitored by measuring absorbance at 
340 nm. Km for acetoacetate was determined with various concentrations of acetoacetate (0.2 to 50 mM) in 
the presence of 0.25 mM NADH. Km for NADH was determined with various concentrations of NADH 
(0.01 to 0.25 mM) in the presence of 25 mM acetoacetate. 
 
Crystallization and data collection  
Crystallization was carried out at 293 K with the hanging-drop vapor-diffusion method using 
15-17% (w/v) PEG8000, 100 mM MgCl2, and 100 mM HEPES-Na buffer pH 7.5 as a reservoir solution. 
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The binary complex of the wild-type enzyme with NAD+ was crystallized by equilibrating a droplet of 2 μl 
solution (39.8 mg/ml protein solution containing 4 mM NAD+ mixed with the same amount of a reservoir 
solution) against 500 μl of the reservoir solution. Crystallization of the ternary complex was carried out 
with the same method as the binary complex using 37.7 mg/ml protein solution containing 8 mM NAD+ and 
25 mM L-3-HB. The crystals of mutant enzymes, T190S and T190A mutants, were obtained by the same 
method as the wild-type enzyme using 30.0 mg/ml protein solution containing 24 mM NAD+ and 50 mM 
L-3-HB. After 1 week, column crystals grew to average dimensions of 0.1x 0.05x 0.5 mm. 
The data were collected at 100 K using a wavelength of 1.0000 Å from the synchrotron radiation 
source at the Photon Factory BL17 station (Tsukuba, Japan) with an ADSC Quantum Q270 CCD detector 
system and the Spring-8 BL38B1 station (Hyogo, Japan) with a RIGAKU Jupiter210 CCD detector system. 
To collect data under cryogenic conditions, crystals were soaked for a few seconds in a solution containing 
30% (v/v) glycerol, 18% (w/v) PEG 8000, 200 mM MgCl2, and 100 mM HEPES-Na buffer pH 7.5. Crystals 
were mounted in a nylon loop and flash-cooled in a nitrogen stream at 100 K. All data sets were processed 
and scaled using HKL2000 (Table 2) (16).   
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Structure determination and refinement  
        We have reported the structures of HBDH from P. fragi complexed with cacodylate (PDB 
code: 1WMB, open-form) and of NAD+ and cacodylate (PDB code: 1X1T) (5, 17). Those crystals belong to 
the space groups P21212 and I222, respectively. Meanwhile, the crystals obtained under new condition 
without cacodylate belong to the space group P212121 with the following cell constants: a = 73.2, b = 106.8, 
and c = 163.2 Å on the binary complex. One tetramer is found in an asymmetric unit, and 59% of the crystal 
volume is occupied by solvent. The structure of the binary complex was determined by the molecular 
replacement method with a tetramer constructed from １WMB as an initial model using the program 
Molrep (18) in the CCP4 program suite (19). The structure of the binary complex was refined by simulated 
annealing and energy minimization using the CNS program (20). The structure was scrutinized by 
inspecting the composite omit map using the program Coot (21). A difference map obviously displayed a 
residual peak from the NAD+ at the active site in each subunit. After several rounds of refinement using the 
program Refmac5 (22) in the CCP4 program suite (19) and manual rebuilding, water molecules were 
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picked up on the basis of the peak height and the distance criteria from the difference map using the Coot 
program (21).  On a difference map, one peak was found to be assigned a glycerol molecule by considering 
the shape, size, peak height, and possible interactions of this peak with neighboring amino acid residues; 
two high peaks were found at positions corresponding to center of symmetry of the dimmer. Since two 
peaks were located at the center of face-to-face C-terminal carboxyl groups, these were assigned as 
magnesium ions six-coordinated to two carboxyl groups and four water molecules. Further model building 
and refinement cycles resulted in an Rfactor of 20.0% and Rfree of 23.5%, using 88463 reflections from 20 to 
1.95 Å resolution (Table 2). The structure of the ternary complex was refined in the same way as that of the 
binary complex. At each active site, the difference Fourier map showed the residual peaks corresponding to 
NAD+ and L-3-HB. From the result of model building and refinement cycles, the Rfactor and Rfree values were 
reduced to 19.8% and 22.8%, respectively, calculated for 115106 reflections from 20 to 1.80 Å resolution 
(Table 2). The structures of two mutants were refined in the same way. In the T190S mutant, an NAD+ was 
found in three subunits of the tetramer, and an L-3-HB was bound to one of them. In the T190A mutants, an 
NAD+ was found in three subunits of the tetramer. After several rounds of model building and refinement, 
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the Rfactor and Rfree values on the T190S and 190A mutants were reduced to 22.7% and 26.6% using 54951 
reflections from 20 to 2.3 Å resolution, and 23.8% and 26.8% using 81824 reflection from 20 to 2.0 Å 
resolution, respectively (Table 2). 
 
PDB accession codes 
The atomic coordinates and structure factors for wild-type enzyme complexed with NAD+ (the 
binary complex), wild-type enzyme complexed with NAD+ and L-3-HB (the ternary complex), T190S 
mutant, and T190A mutant (PDB code: 2ZTV, 2ZTL, 2ZTM, and 2ZTU) have been deposited in the 
Worldwide Protein Data Bank (wwPDB; http://www.wwpdb.org) and in the Protein Data Bank Japan at the 
Institute for Protein Research, Osaka University (PDBj; http://www.pdbj.org/). 
 
RESULTS 
Expression and purification of the various HBDH mutants 
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Among the residues involved in the substrate specificity, 6 strictly conserved residues were 
chosen for site-directed mutagenesis. To simplify the purification of the wild-type and mutant HBDHs, a 6 
x histidine tag was introduced to their N-termini. All the mutants were well expressed to similar levels, and 
the expressed enzymes were efficiently purified by metal chelating affinity chromatography followed by 
ion-exchange chromatography on a Toyopearl SuperQ-650C column. A comparison of the kinetic 
parameters between the wild-type HBDH with the histidine tag and that without showed that both HBDHs 
have almost the same enzymatic characteristics. This indicated that the N-terminal histidine tag did not 
interfere with enzyme activity. This agrees well with the structure determined previously, in which the 
N-terminus of the enzyme is located far from the active site and is not involved in subunit interactions. The 
kinetic parameters are summarized in Table 3.  
 
Recognition of the carboxyl group 
Gln94, His144, Lys152, and Gln196 were replaced by alanine. Large decreases in activity were 
observed for all the alanine mutants. Lys152 was found to be essential, since no activity was detected for the 
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K152A mutant. The catalytic efficiencies (kcat/Km) of Q94A and H144A were 1.4% and 0.2% of the activity 
of wild-type HBDH, suggesting these residues contributed significantly to the carboxyl recognition. 
Arginine substitution for lysine showed a significant level of activity. The Km value was 40-fold that of the 
wild type, while the kcat value was approximately 40% that of the wild type, indicating not only the 
importance of a positive charge to interact with the carboxyl group of the substrate but also that the positive 
charge was not directly involved in the catalytic reaction.  
 
Recognition of the 3-methyl group 
Trp187 and Trp257 were mutated. Very little activity was detected for the W187A mutant, and 
none was found for the W257A mutant. This is in good agreement with the finding that Trp257 was strictly 
conserved among various HBDH sequences. The residue at position 187 was often a tryptophan, but 
tyrosine and phenylalanine could be found in some bacterial HBDH sequences. We also made tyrosine and 
phenylalanine substitutions for these Trp residues. W187F and W187Y mutants showed significant activity 
levels--65% and 41% that of the wild-type enzyme, respectively. W257F and W257Y showed only faint 
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levels--2% and 1% of that of the wild-type enzyme, respectively. The decrease in W187A activity was 
mainly due to the 100-fold increase in Km value, suggesting that a bulky hydrophobic residue is required at 
this position to accommodate the 3-methyl group of the substrate. Tyrosine and phenylalanine may be 
sufficient in this regard. However, as the decreased kcat values for W187F and W187Y suggest, tryptophan 
was preferable for fixing the substrate to a better orientation. It can be concluded that Trp257 is essential for 
enzyme activity. In addition, a W187T mutant was constructed to investigate the very low activity of the 
human type 2 HBDH (12). The overall structures of P. fragi HBDH and human type 2 HBDH are very 
similar despite their low sequence identity (18%). Most of the functional residues important for substrate 
recognition and enzymatic activity are conserved except for Lys152 and Trp187, which are Arg144 and 
Thr179, respectively, in human type 2 HBDH. W187T showed faint activity. Since the K152R mutant 
retained a significant level of activity, Thr179 in the human type 2 HBDH may be the major cause of its low 
activity, although the functional relevance of Thr179 is unclear.  
 
Interaction between substrate entry loop and the LHB 
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In our previous model, Pro191-Glu214, which corresponded to the substrate binding loop of the 
closed form of P. fragi HBDH, were missing. This region shows a limited sequence identity and is very 
important for substrate recognition in individual SDR enzymes. For mutagenesis, we chose Gln196, which 
is strictly conserved among HBDH sequences. The kcat/Km value of the Q196A mutant was only 0.6% that 
of the wild type, and substitution by glutamate and aspartate also substantially reduced activity. As 
described later, Gln196 formed a hydrogen bond with the carboxyl group of the substrate.  
 
Importance of the residues functioning as hinges 
Comparison of the open- and closed-form structures clearly showed the conformational change 
of the two key residues, Thr190 and Leu215, to enable the hinge movement of the substrate-binding loop as 
hinges (5). Thr190 was replaced by serine, alanine, and cysteine, and Leu215 was replaced by valine and 
alanine. These mutants were expressed without histidine tags and purified to homogeneity for both kinetic 
and crystallographic analyses. Since the hydroxyl group of Thr190 was considered to interact with a 
pyrophosphate and a carboxamide of NAD+ molecules, we determined the kinetic parameters for D-3-HB, 
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acetoacetate, NAD+, and NADH (Table 4). As expected, significant activity was observed for T190S. The 
mutations increased the Km values 2- to 4-fold but did not decrease the kcat values, which indeed even 
slightly increased. In the T190A mutant, Km and kcat values showed a much larger increase and decrease, 
respectively. The activity was decreased also in T190C. We tried to measure the activity of the T190C 
mutant at pHs below the optimum of 8.5. The activity ratio of T190C and the wild type were similar through 
the pH range tested, indicating that the sulfhydryl group cannot substitute for the hydroxyl group of Thr190.  
Interestingly, similar changes in kinetic parameters were observed for Leu215 mutants. In the 
L215V mutant, Km values increased 3.5- and 4.3-fold and the kcat values were 73% to 118% those of the 
wild-type toward D-3-HB and acetoacetate, respectively. The mutation did not significantly change Km and 
kcat toward NAD
+ and NADH. In the L215A mutant, both Km and kcat values were largely affected and the 
catalytic efficiency (kcat/Km) was less than 3% that of the wild-type enzyme.  
  
Qualities of the structures 
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The final model of the binary complex contains a homotetramer composed of 260, 246, 255, and 
253 amino acid residues (subunits A, B, C, and D, respectively), four NAD+, two magnesium ions, a 
glycerol, and 578 water molecules, with an R-factor of 20.0% at 1.95 Å resolution. The model lacks 26 
residues (Glu196-Glu209, Leu200-Asn204, and Ala199-Gly205 in chains B, C, and D, respectively), and 
the average thermal factors of the main chain atoms at subunits A, B, C, and D are 34.6, 46.3, 31.6, and 33.7 
Å2, respectively. Analysis of the stereochemistry with PROCHECK (23) showed that all of the main chain 
atoms fall within the generously allowed region of the Ramachandran plot, with 784 residues in the most 
favored region, 73 residues in the additionally allowed region, and 2 residues in the generously allowed 
region. The ternary complex contains a homotetramer, each of whose subunits contains 260 amino acid 
residues, four NAD+, four L-3-HB, two magnesium ions, and 836 water molecules, with an R-factor of 
19.8% at 1.80 Å resolution. The average thermal factor of main chain atoms at subunits A, B, C and D are 
23.9, 37.7, 23.9, and 24.0 Å2, respectively. Analysis of the stereochemistry with PROCHECK showed that 
815, 70, and 3 residues fall within the most favored, the additionally allowed, and the generously allowed 
regions of the Ramachandran plot, respectively. The T190S mutant contains a homotetramer composed of 
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255, 224, 250, and 247 residues (subunits A, B, C and D, respectively), three NAD+, an L-3-HB, two 
magnesium ions, and 408 water molecules, with an R-factor of 22.7% at 2.30 Å resolution. The model lacks 
55 residues (Gly37-Ala47 and Pro191-Ala211 in subunit B, Asn204-Arg213 in subunit C, and 
Leu200-Ala212 in subunit D). The average thermal factor of main chain atoms at subunits A, B, C, and D 
are 41.7, 57.5, 31.6, and 37.0 Å2, respectively. Analysis of the stereochemistry with PROCHECK showed 
that 716, 106, and 2 residues fall within the most favored, the additionally allowed, and the generously 
allowed regions of the Ramachandran plot, respectively. The T190A mutant contains a homotetramer 
composed of 245, 214, 242, and 241 residues (subunits A, B, C, and D, respectively), three NAD+, two 
magnesium ions, and 633 water molecules, with an R-factor of 23.8% at 2.0 Å resolution. The model lacks 
108 residues (Ala190-Glu214 in subunit A, Gly37-Val57 and Arg189-Arg213 in subunit B, Ala190-Asp207 
in subunit C, and Ala190-Glu208 in subunit D). The average thermal factors of main chain atoms at 
subunits A, B, C, and D are 31.3, 47.5, 31.7, and 28.5 Å2, respectively. Analysis of the stereochemistry with 
PROCHECK showed that 690, 83, and 2 residues fall within the most favored, the additionally allowed, and 
the generously allowed regions of Ramachandran plot, respectively. Refinement statistics is summarized in 
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Table 2. Structure diagrams were drawn with the Molscript (24) POVscript+  (25), and Raster3D (26) 
programs. 
 
Overall and subunit structures  
The structure of the ternary complex with NAD+ and L-3-HB was determined. As shown in 
Figure 1a, four subunits, except for the substrate-binding region in the ternary complex, were superimposed 
using a least-squares method at Cα positions on the open-formed structure of 1WMB with rms deviation 
values of 0.28-0.35 Å. The structure of the substrate-binding region of the ternary complex was 
significantly different from that of the open form and was considered a closed form of the HBDH. In fact, 
the conformation of subunit A was similar to that of HBDH complexed with NAD+ and acetate anion from 
Alcaligenes faecalis (PDB code: 2ZEA) (14), and two structures can be superimposed with an rms 
deviation value of 0.48 Å.  
The subunit structures of the binary complex with NAD+ were compared with those of the open 
and closed forms, as shown in Figure 1b. Four subunits, except for the substrate-binding regions, were 
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superimposed on the open form with rms deviation values of 0.27-0.37 Å. The conformation of the 
substrate binding regions at subunit A apparently corresponded to the closed form, and those of subunits B, 
C, and D were found to exist as open forms, although a part of the substrate binding region was disordered.  
Each subunit structure of the T190S and T190A mutants was superimposed using a least-squares 
method on the open-form structure with an rms deviation value of approximately 0.30 Å. At every active 
site of the T190S mutant except for subunit B, a Fourier peak was identified as an NAD+. Only one peak 
was obviously observed at the active site of subunit A, corresponding to L-3-HB. The same peak was 
obscure in the other subunits. From the comparison of subunit structures shown in Figure 1c, the 
conformation of subunit A clearly adopted the closed form, and the others were also considered to have the 
closed form. In the T190A mutant, a Fourier peak corresponding to NAD+ was observed at the active site 
except for that of subunit B. Although the crystallization solution contained the same concentration of 
L-3-HB as used for T190S, Fourier peaks from L-3-HB were not found at any of the active site in the 
subunits. The conformation of the subunits corresponded approximately to the open form shown in Figure 
1d. The conformation of Trp187, which is important in recognizing the 3-methyl group of a substrate, 
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changes upon substrate binding (5). In the T190A mutant, the conformation of Trp187 in subunits A and C, 
or that in subunits B and D, mainly had an open or closed form, respectively, indicating that the crystal 
structure of the T190A mutant contains a mixture of two conformations. Conformations of the individual 
subunits in various complexes are summarized in Table 5. 
 
Closed conformation of HBDH 
All the subunits of the ternary complex with NAD+ and L-3-HB had a closed-form conformation. 
A comparison of this with the structure having the open-form conformation revealed that the substrate 
binding region, Thr190-Leu216, which is composed of two helices and a connecting loop, was rotated 
approximately 28° from its position in the open form in order to close the active site (Figure 2). Thr190 and 
Leu216 were significantly different from the other residues except for Gly in the torsion angle of the main 
chain between the open and closed forms (Table 6). The variations in the torsion angles φ and ψ were -19.0° 
and 7.4° at Thr190, and 20.0° and -29.7° at Leu216, respectively. This indicates that the substrate binding 
region rotated on Thr190 and Leu216 as center of hinges. As a result of this conformational change, the side 
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chain of Thr190 was rotated approximately 37°, and a hydroxyl group of Thr190 formed a hydrogen bond 
to the pyrophosphate moiety of NAD+ with a distance of 2.49 Å.  In addition, the active site was covered by 
Leu192 and Val193, which were located on the substrate binding region, at displacements of 5.07 and 3.43 
Å, respectively, thus separated from solvent. Trp187 was involved in the recognition of the 3-methyl group 
of a substrate at χ2 angle variation of 26.3°. The rotation of Trp187 was induced by a displacement of 
Leu215 with 2.27 Å. Leu215 that is located at the hinge region formed a hydrophobic interaction to Trp187. 
The L-3-HB is tightly bound to the active site in each subunit, as shown in Figure 3. The mean 
thermal factors of L-3-HB were 25.4, 38.6, 28.9, and 36.4 Å2 in subunits A-D, respectively.  The 3-methyl 
group binds to a hydrophobic pocket consisting of Ala143, His144, Gly186, Trp187, and Trp257. The 
3-hydroxyl group forms hydrogen bonds with Ser142 and Tyr155 at distances of 2.45 and 2.54 Å, 
respectively. The carboxyl group is recognized by Gln94, His144, Lys152, and Gln196, to which the 




We have determined two structures of the HBDH from P. fragi (PDB code: 1WMB, 1X1T) in the 
presence of a competitive inhibitor, cacodylate (5). The subunit of HBDH is composed of a typical 
Rossmann fold and the substrate-binding region. The subunit can change its conformation from open to 
closed form upon substrate binding, as do other members of the SDR family. One of the two structures, 
1WMB, is an open form, and a cacodylate anion is bound to the active site. The other is the ternary complex 
of HBDH-NAD+-cacodylate. This ternary complex is considered to have a closed form, although its 
substrate-binding region is disordered. Cacodylate anion is a competitive inhibitor, and the structural 
difference between cacodylate and D-3-HB causes the disorder in the substrate-binding region, as described 
previously (5). In the present study, the closed form structure containing the substrate-binding region was 
determined by using crystals obtained from cacodylate-free buffer in the presence of NAD+ and L-3-HB. 
The crystal structure of the ternary complex of HBDH-NAD+-L-3-HB instantly confirmed our 
hypothesis that stringent stereo-specificity was achieved through the recognition of the carboxyl group and 
the methyl group of the substrate. The substrate molecule fixed at both ends of its carbon chain was covered 
by the substrate-binding loop. The hydrogen atom at the 3-position of L-3-HB faced away from the 
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4-position of the nicotinamide ring in the complex. In the case of D-3-HB, effective hydride transfer can 
take place. In addition, the structure also explains why the Ki value of L-3-HB was comparable to the Km 
value of the D-3-HB.  
In the HBDH-NAD+-L-3-HB complex, closed form is observed for all chains A, B, C, and D of 
the tetramer. The closed form is confirmed from the conformations of Thr190 and Leu216. O3 of the 
L-3-HB forms hydrogen bonds to the hydroxyl groups of Tyr155 and Ser142. The carboxyl group of the 
L-3-HB is bound to the side chains of His144, Lys152, Gln94, and Gln196 by hydrogen bonds of lengths 
2.97, 2.81, 2.81, and 2.68 Å, respectively. These residues are strictly conserved among bacterial HBDH 
sequences, and this binding occurs in almost the same manner as we suggested from the binding mode of 
cacodylate in our previous paper. The methyl group at the 3-position of the L-3-HB is accommodated by the 
hydrophobic pocket consisting of Ala143, Trp187, and Trp257, which are also the same residues as we 
suggested in our previous paper. We confirmed these interactions by site-directed mutagenesis. Our data 
are consistent with those reported by Feller et al (28). The enzyme recognizes the carboxyl and 3-methyl 
groups. The Km for D-3-HB is comparable to the Ki for L-3-HB. If the enzyme accommodates the 3-methyl 
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group of two enantiomers tightly and in exactly the same way, it may be difficult to form a hydrogen 
bonding interaction between the 3-hydroxyl group of the L-3-HB and Tyr155. However, the 3-hydroxyl 
group forms hydrogen bonds with Ser142 and Tyr155, as described above. There appears to be some 
allowance between the inhibitor/substrate and the enzyme. In order to bind the real substrate D-3-HB, the 
positions of the C2 and C3 atoms must be shifted by approximately 1-2 Å from the corresponding positions 
of the L-3-HB, as shown in Figure 4. A small clearance of the substrate-binding pocket allows the enzyme 
to bind L-3-HB, and this binding is achieved through the same interactions for D-3-HB, which includes the 
recognition of the carboxyl-, 3-methyl-, and 3-hydroxyl groups. As a result, the enantiomeric inhibitor of 
the substrate can induce the conformational change to the closed form. No D-3-HB was identified in HBDH 
crystals obtained from the buffer containing NAD+ and D-3-HB, probably because the catalytic reaction 
proceeded. Then we tried to obtain crystals of the Y155F-NAD+-D-3-HB complex. If the enzyme 
recognizes D-3-HB mainly by its carboxyl and methyl groups, a closed conformation might be formed. No 
D-3-HB molecule was observed in the crystals of Y155F enzyme made in the presence of NAD+ and 
D-3-HB (data not shown), indicating that Tyr155 is essential not only for catalysis but also for substrate 
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binding. The Y155F mutant enzyme exists basically as an open conformation in the complex. Chain A 
seems to be a closed form, but it is not possible to confirm the conformations of the other chains because 
they are partially disordered. Although the disorder may be an indication of the NAD+-induced 
conformational change to the closed structure, a stable ternary complex was not observed. Tyr155 forms a 
hydrogen bond to the nicotinamide ribose and may influence NAD+ binding.  
Paithankar et al. reported that the closure of the substrate-binding loop was induced by 
cosubstrate binding in Pseudomonas putida HBDH (PpHBDH) (13). In 3α-hydroxysteroid dehydrogenase, 
the loop-helix transition was induced by coenzyme binding (29). To clarify the mechanism underlying the 
conformational change in PfHBDH, we used a highly purified preparation of the wild-type HBDH, which 
has been extensively dialyzed against an excess volume of 10 mM Tris-HCl buffer (pH 7.5). Crystals of the 
HBDH-NAD+ binary complex were made in the presence of 4 mM NAD+. As shown in Figure 1b, chain A 
was found to be a closed form. The other chains (B, C, and D) remained in the open form. Importantly, 
NAD+ molecules were identified in all four chains with almost the same conformation. Similar patterns 
were observed for the crystals made in the presence of CaCl2 instead of MgCl2. Crystals of PpHBDH were 
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prepared in the presence of NAD+, acetoacetate, and CaCl2. The closed conformation observed in the 
PpHBDH-NAD+ complex might have been mediated by the acetoacetate in the crystallization buffer. The 
closed conformation was also described for the structure of AfHBDH, which has been determined recently 
by Hoque et al (14). They assigned the acetate ion in the crystal structure and constructed a substrate-bound 
model from the acetate complex. These observations suggest that the NAD+ binding makes HBDH 
competent to adopt a closed form but it is not sufficient for shifting the equilibrium from an open to a closed 
form. In contrast, all 4 chains of the HBDH-NAD+-L-3-HB complex had a closed form. Comparable values 
between Km for L-3-HB and Ki for L-3-HB are consistent with the similar interactions of carboxyl-, 
3-methyl-, and 3-hydroxyl groups with the enzyme. These observations indicate that the substrate/inhibitor 
binding is required for the stable ternary complex formation.  
In many of the crystal structures of SDR enzymes, the substrate-binding loop region is ordered 
in the presence of cofactor but is disordered in its absence (7). The disordered structure of the 
substrate-binding loop in the crystal of the PfHBDH-NAD+-inhibitor (PDB code: 1X1T) was caused by the 
difference in the structures between the substrate and the inhibitor. We hypothesized that the disorder was 
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caused by a steric hindrance between a methyl group of a cacodylate and the moving substrate-binding loop. 
The structures of HBDH-cacodylate binary complex (PDB code: 1WMB) and HBDH-NAD+-cacodylate 
ternary complex were superimposed onto that of the HBDH-NAD+-L-3-HB ternary complex, and the active 
site of the HBDH-NAD+-L-3-HB is shown along with the cacodylate anions in Figure 5. Unexpectedly, the 
cacodylate molecule of 1X1T can be placed without steric hindrance in the space where the L-3-HB is 
bound. This is possible because the enzyme has some allowance, as already described. L-threonine can be 
bound to the active site for the same reason, but the binding is weak because of the presence of the 
hydrophilic amino group facing the hydrophobic tryptophan residue. The major difference between 
cacodylate and hydroxybutyrate must be their negative charges. The carboxyl group can form a hydrogen 
bond with Gln196 on the substrate-binding loop and stabilize the closed conformation of the ternary 
complex. The negative charge on the cacodylate anion, however, cannot interact with Gln196, leading to a 
disorder of the substrate-binding loop. Substitution for Gln196 drastically decreased activity, mainly due to 
the large increase in the Km value for D-3-HB. Compatible with these experimental data, Gln196 is a critical 
residue not only for substrate binding but also for the stabilization of the closed conformation.  
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The substrate-binding loop moves as a rigid body upon substrate binding. We reported Thr190 
and Leu215 functioned as hinge for the open-closed conformational change because these residues 
significantly changed the conformation between enzyme-cacodylate complex (open form) and 
enzyme-NAD+-cacodylate complex, of which substrate-binding loop was disordered (5). In this study, 
Arg189-Leu192 and Leu215-Ser217 appear to function as hinges for the conformational change, and a 
center of the hinge regions was Thr190 and Leu216, respectively. The site-directed mutagenesis of Thr190 
confirmed the importance of the hydroxyl group. The hydroxyl group of Thr190 interacts with the 
phosphate and carboxamide groups of NAD+. No direct contact is observed between Thr190 and the 
substrate/inhibitor. As shown in Table 4, T190S substitution affected only Km, and kcat was even slightly 
increased, indicating that the Thr190 contributed significantly to substrate binding. This must be due to the 
interaction between Gln196 and the substrate. The closed conformation was confirmed in the crystal 
structure of the T190S enzyme-NAD+-L-3-HB complex. The methyl group of the Thr190 residue may be 
involved in the stability of the closed form. Similarly, Leu215 is also important for the 
substrate/inhibitor-induced conformational change. Since Leu215 has no direct interaction with 
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NAD+/NADH, Km values toward the cofactor were not significantly affected. The increase in Km values 
toward D-3-HB may be a result of the destabilization of the closed conformation. The isopropyl side chain 
may be sufficient for binding the substrates and catalysis of the reaction in association with Trp187. The 
small methyl side chain in L215A mutant, however, may not fully support the binding of the substrate and 
catalysis. We are now trying to crystallize the Leu215 mutants to clarify the role of Leu215 residue.  
In conclusion, we have determined the crystal structure of the closed complex induced by 
L-3-HB, an enantiomeric competitive inhibitor, and clarified the importance of the interaction between the 
hydroxyl groups of the substrate/inhibitor and the active site tyrosine. To our knowledge, this may be the 
first crystal structure of the SDR family to have the enantiomeric competitive inhibitor-induced closed form, 
and should provide a good model to investigate the open-closed conformational change of the family. By 
using a pure enzyme preparation, which was free from substrate analogs, the crystal structure of the 
PfHBDH-NAD+ binary complex was also determined, and the open conformation predominated. The hinge 
regions, Thr190 and Leu215, are important for the conformational change upon substrate binding. The 
cofactor binding may trigger the conformational change of the substrate-binding loop and make the enzyme 
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competent for the closed form; however, this is not sufficient for the stable formation of the ternary 
complex in the closed conformation.  
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Table 1. Mutagenic and flanking primers 
Mutation   Nucleotide sequence Flanking primers Restriction sites 
  up down up down 
Q94A 5'-CGCCGGCATCGCGCACACCGCGCTG-3' ATG15 17a NcoI BglII 
H144A 5'-CGCCTCGGCGGCCGGCCTGGTGGC-3' 19s 17a NcoI BglII 
K152A 5'-GGCCAACGCGTCGGCCTACG-3' 19s 17a NcoI BglII 
K152R 5'-CGGCCAACCGGTCGGCCTACGTCGC-3' 19s 17a NcoI BglII 
K152Q 5'-CGGCCAACCAGTCGGCCTACGTCGC-3' 19s 17a NcoI BglII 
K152E 5'-CGGCCAACGAGTCGGCCTACGTCGC-3' 19s 17a NcoI BglII 
Y155F 5'-GGCCAACAAGTCGGCCTTCGTCGCCG-3' 19s 17a NcoI BglII 
W187A 5'-CTGCCCGGGCGCGGTGCGCACTC-3' 19s 17a BstEII BglII 
W187F 5'-CTGCCCGGGCTTCGTGCGCACTC-3' 19s 17a BstEII BglII 
W187Y 5'-CTGCCCGGGCTACGTGCGCACTC-3' 19s 17a BstEII BglII 
W187T 5'-CTGCCCGGGCACGGTGCGCACTC-3' 19s 17a BstEII BglII 
T190A 5'-GGTGCGCGCTCCGCTGGTCG-3' 19s 17a NcoI BglII 
T190S 5'-GGGTGCGCTCTCCGCTGGTCG-3' 19s 17a NcoI BglII 
T190C 5'-GGGTGCGCTGTCCGCTGGTCG-3' 19s 17a NcoI BglII 
Q196A 5'-CTGGTCGAAAAGGCGATCTCGGCGC-3' 19s 17a NcoI EspI 
Q196N 5'-CTGGTCGAAAAGAACATCTCGGCGC-3' 19s 17a NcoI EspI 
Q196E 5'-CTGGTCGAAAAGGAAATCTCGGCGC-3' 19s 17a NcoI EspI 
L215A 5'-GCGCGCGAAGCCCTCAGCGAAAAGC-3' 19s HIII-T7 NcoI SacII 
L215V 5'-GCGCGCGAAGTCCTCAGCGAAAAGC-3' 19s HIII-T7 NcoI SacII 
W257A 5'-CGATGGCGGCGCGACGGCGCGCTG-3' 19s HIII-T7 NcoI SacII 
W257F 5'-CGATGGCGGCTTCACGGCGCGCTG-3' 19s HIII-T7 NcoI SacII 
W257Y 5'-CGATGGCGGCTACACGGCGCGCTG-3' 19s HIII-T7 NcoI SacII 
 
Flanking primers  
19s 5'-GCACACCGCGCTGATCGAGGAC-3'  
17a 5'-CGAATTGCAGCGACGGCTGCT-3'  




Table 2. Data collection and refinement statistics 
 
   binary complex ternary complex T190S mutant T190A mutant  
Data collection
 Space group P212121 P212121 P212121 P212121 
 Cell parameter 
  a (Å) 73.23 74.02 73.79 73.12 
  b (Å) 106.8 106.4 105.9 106.6 
  c (Å) 163.2 165.2 164.5 164.8 
 Wavelength 1.000 1.000 1.000 1.000 
 Resolution range (Å) 50-1.95 (2.02-1.95) 50-1.80 (1.86-1.80) 50-2.30 (2.38-2.30) 50-2.00 (2.07-2.00) 
 Number of unique reflections 93683 (9248) 121412 (11952) 58373 (5751) 86335 (7621) 
 Completeness (%) 99.9 (100) 99.6 (99.2) 99.9 (99.5) 98.6 (88.1) 
 Redundancy 7.2 (7.3) 6.9 (6.4) 5.2 (4.2) 5.4 (4.3) 
 Rmerge 0.053 (0.302) 0.058 (0.323) 0.086 (0.359) 0.065 (0.280) 
 Mean I/σ(I) 50.2 (9.0) 47.3 (6.6) 21.2 (2.9) 27.9 (3.0) 
 Willson B 27.3  22.4  43.1  28.3 
 
Refinement 
 Resolution range (Å) 20-1.95 (2.00-1.95) 20-1.80 (1.84-1.80) 20-2.30 (2.38-2.30) 20-2.00 (2.07-2.00) 
 R-factor 0.200 (0.265) 0.198 (0.244) 0.227 (0.273) 0.238 (0.286) 
 Rfree 0.235 (0.321) 0.229 (0.283) 0.266 (0.320) 0.268 (0.305) 
 Root mean square deviation 
  Bond lengths (Å) 0.019 0.015 0.006 0.005 
  Bond angles (°) 1.61 1.48 1.21 1.17 
 Average B-factor (Å2) 
  protein chain 35.8 27.3 42.2 32.7 
  waters 39.5 35.2 40.7 40.1 
  NAD+ 46.0 26.5 41.3 48.1 
  L-3HB - 32.3 47.3 - 
 Ramachandrant plot     
  most favored region 784 (91.3%) 815 (91.8%) 716 (86.9%) 690 (89.0%) 
  additional allowed region 73 ( 8.5%) 70 ( 7.9%) 106 (12.9%) 83 (10.7%) 
  generously allowed region 2 ( 0.2%) 3 ( 0.3%) 2 ( 0.2%) 2 ( 0.3%)
Rmerge = ∑hkl ∑i | I hkl,i - <I hkl> | / ∑ hkl ∑ i I hkl,i , where I = observed intensity and <I> = average intensity for multiple measurements. 
Values in parentheses refer to the last resolution shell   
Table 3. Kinetic parameters of various HBDH mutants for D-3-hydroxybutyrate. 
Enzyme D-3-HB   NAD+  
 Km kcat kcat/Km Km kcat/Km 
 (mM) (s-1) (s-1 mM-1) (mM) (s-1 mM-1) 
Wild-type 0.80 370 463 0.24 1540 
H6-HBDH 0.88 310 352 0.17 1820 
H6-Q94A 30 140 4.7 0.19 737 
H6-H144A 25 21 0.8 0.35 60 
H6-K152A  very low activity    
H6-K152R 31 110 3.5 0.12 917 
H6-K152Q  very low activity    
H6-K152E  very low activity    
H6-Q196A 47 99 2.1 0.12 825 
H6-Q196N 51 22 0.4 0.20 110 
H6-Q196E 83 83 1.0 0.12 692 
 
H6-Y155F  No activity   
 
H6-W187A 100 29 0.3 0.76 38 
H6-W187F 1.3 310 238 0.24 1290 
H6-W187Y 1.2 180 150 0.21 857 
H6-W187T 84 7.2 0.09 0.88 8.2 
H6-W257A 61 6.7 0.1 0.95 7.0 
H6-W257F 83 88 1.1 0.49 180 
H6-W257Y  65 12 0.2 0.74 16 
 
 
Table 4. Kinetic parameters of Thr190 and Leu215 mutants 
Enzyme D-3-HB    NAD+  acetoacetate   NADH 
 Km kcat kcat/Km Km kcat/Km Km kcat kcat/Km Km kcat/Km 
 (mM) (s-1) (s-1 mM-1)  (mM) (s-1 mM-1)  (mM) (s-1) (s-1 mM-1)  (mM) (s-1 mM-1)  
 
Wild type 0.80 370 463 0.24 1540 0.37 120 324 0.01 12000 
 
T190S 3.7 705 191 0.71 993 1.1 125 114 0.02 6250 
 
T190A 25 22 0.9 2.2 10 32 4.5 0.14 0.10 45 
 
T190C 36 6.1 0.2 0.69 9 7.7 5.1 0.66 1.5 3.4 
 
L215V 3.4 435 128 0.29 1500 1.3 87 67 0.03 2900 
 




Table 5. Conformation of the individual subunits in various complexes of the wild-type, T190S, and T190A 
HBDHs. 
Enzyme PDB code Subunits 
  A B C D 
Open form 1WMB open open - - 
 
 
Enzyme-NAD+- 1X1T closed - - - 
cacodylate complex  (disordered)  
 
Binary complex 2ZTV closed open open open 
   (disordered) (disordered) (disordered) 
 
Ternary complex 2ZTL closed closed closed closed 
 
 
T190S mutant 2ZTM closed closed closed closed 
   (disordered) (disordered) (disordered) 
 
T190A mutant 2ZTU open open open open 
  (disordered) (disordered) (disordered) (disordered) 
ASU contains 2 subunits and 1 subunit in 1WMB (P21212) and 1X1T (I222), respectively. For 2ZTV, 2ZTL, 
2ZTM, and 2ZTU, ASU contains 4 subunits with a space group of P21212.  
 



















 Residues Δφ (°) Δψ (°)  
 Val188 -3.2 -7.5 
 Arg189 -2.7 -1.7 
 Thr190 -19.0 7.4 
 Pro191 1.8 9.9 
 Leu192 10.6 -12.1 
 Val193 -8.9 -2.3 
 
 Glu214 -8.8 0.7
 Leu215 5.5 -6.7 
 Leu216 20.0 -29.7 
 Ser217 -20.5 13.8 
 Glu218 11.1 -0.3 
Figure 1 
 (a) (b) 
 













(b)  (c) 
Figure 5 
 
 
